747 Bladder cancer and seroreactivity to BK, JC and Merkel cell polyomaviruses: The Spanish bladder cancer study

What’s new bladder cancer research?

“…The Spanish Bladder Cancer Study evaluated antibody responses against MCV, BKC and JCV in 1135 patients with incident bladder cancer from five Spanish regions and 982 hospital controls matched by sex, age, and region. 3 A similar seroprevalence was seen between cases and controls for all of the viruses tested. However, among those who were found to be seropositive, patients with bladder cancer had a higher median seroreactivity to BKV (0.84 vs. 0.70; p=0.009) and MCV (1.81 vs. 0.65; p<0.001).…”